Alloxan in vivo does not only exert deleterious effects on pancreatic B cells

Physiological Research

Volumn 47, Issue 5, 1998, Pages 343-346

  Szkudelski, T ^a   Kandulska, K ^a   Okulicz, M ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Alloxan; Glucose; Glutathione peroxidase; Insulin; Sulfhydryl groups

Indexed keywords

ALLOXAN; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; THIOL DERIVATIVE;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETOGENESIS; DRUG CYTOTOXICITY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; INSULIN BLOOD LEVEL; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; RAT;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; FASTING; FATTY ACIDS, NONESTERIFIED; GLUTATHIONE PEROXIDASE; INSULIN; ISLETS OF LANGERHANS; LIVER; MALE; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS;

EID: 0031774996     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 14C-leucine into pancreatic islets of rats. Acta. Diabetol. Lat. 17: 135-143, 1980.
2. DEAN P.M., MATTHEWS E.K.: The bioelectrical properties of pancreatic islet cells: effect of diabetogenic agents. Diabetologia 8: 173-178, 1972.
3. DUNCOMBE D.: The colorimetric micro-determination of nonesterified fatty acids in plasma. Clin. Chim. Acta. 9: 122-125, 1964.
4. DUNN J.S., SHEEHAN H.L., MCLETHIE N.G.B.: Necrosis of islets of Langerhans produced experimentally. Lancet 1: 484-487, 1943.
5. FIELD J.B., ROJDMARK S., HARDIND P., ISHIDA T., CHOU M.C.Y.: Role of liver in insulin physiology. Diabetes Care 3: 255-260, 1980.
6. FOSTER L.B., DUNN R.T.: Stable reagents for determination of serum triglycerides by a colorimetric Hatzsch condensation method. Clin. Chem. 19: 338-340, 1973.
7. GORUS F.K., MALAISSE W.J., PIPELEERS D.G.: Selective uptake of alloxan by pancreatic B-cells. Biochem. J. 208: 513-515, 1982.
8. HARMAN A.W., FISCHER L.J.: Alloxan toxicity in isolated rat hepatocytes and protection by sugars. Biochem. Pharmacol. 31: 3731-3736, 1982.
9. KECK F.S., WOLF C.F., VESER W., PFEIFFER E.F.: Liver thiol content under varying glucoregulatory states in rats. Endocrinol. Exp. 24: 379-384, 1990.
10. KLIBER A., SZKUDELSKI T., CHICHXOWSKA J.: Alloxan stimulation and subsequent inhibition of insulin release from in situ perfused rat pancreas. J. Physiol. Pharmacol. 47: 321-328, 1996.
11. KOMATSU M., YOKOKAWA N., TAKEDA T., NAGASAWA Y., AIZAWA T., YAMADA T.: Pharmacological characterisation of voltage-dependent calcium channel of pancreatic B-cell. Endocrinology 125: 2008-2014, 1989.
12. LOWRY O.H., ROSENBURGH N.J., FARR A.L., RANDALL R.J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
13. LENZEN S., FREYTAG S., PANTEN U.: Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme. Mol. Pharmacol. 34: 395-400, 1988.
14. RICE-EVANS C.A., DIPLOCK A.T., SYMONS M.C.R.: Techniques in Free Radical Research. Elsevier, Amsterdam, 1991.
15. SAKURAI K., OGISO T.: Inhibitory effect of glutathione on the generation of hydroxyl radicals in the reaction system of glutathione-alloxan. Chem. Pharm. Bull. 39: 737-742, 1991.
16. SEDLAK J., LINDSAY R.H.: Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25: 192-205, 1968.
17. 2 as an intermediate. J. Biol. Chem. 226: 2112-2114, 1991.
18. 2+ sequestration by toxic agents. Biochem. Pharmacol. 34: 3717-3727, 1985.
19. ZHANG H., ZDOLSEK J.M., BRUNK U.T.: Alloxan cytotoxicity involves lysosomal damage. APMIS 100: 309-316, 1992.